Nick joined Philips in 2016 to help launch Philips Ventures. He’s responsible for executing and managing the fund’s investments in North America. Nick has worked with early-stage technology companies for over 20 years in many capacities: venture investor, board member, investment banker and advisor.
Prior to joining Philips, Nick spent seven years as a venture investor with MassVentures, an early-stage technology venture capital firm aimed at fueling high-growth start-ups in Massachusetts. Before that, Nick was a senior technology investment banker with Oppenheimer & Co., SVB Alliant and Canaccord Genuity (formerly Adams Harkness). He holds an MBA from MIT’s Sloan School of Management and a Bachelor of Science in Business Administration from The University of Richmond.
I’m helping grow the next generation of transformative companies that could significantly improve what really matters: people's health.”
You are about to visit a Philips global content page
ContinueThe information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.